Alcon (ALC) Total Current Liabilities (2009 - 2026)
Alcon (ALC) posted quarterly Total Current Liabilities of $3.0 billion for Q1 2026, down 1.48% on a QoQ basis from $3.0 billion in Q4 2025.
Alcon (ALC) Total Current Liabilities (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Total Current Liabilities for 11 consecutive years, with $3.0 billion the latest figure, recorded in Q1 2026.
- Quarterly Total Current Liabilities changed N/A year-over-year to $3.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 billion (changed N/A YoY) and the FY2025 annual result came in at $3.0 billion, up 33.85% from the prior year.
- Total Current Liabilities declined to $3.0 billion in Q1 2026 per ALC's latest filing, from $3.0 billion in the prior quarter.
- Over the last five years, Total Current Liabilities for ALC reached as high as $3.0 billion in Q4 2025 and fell as low as $2.2 billion in Q1 2022.
- A 5-year average of $2.5 billion and a median of $2.4 billion in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities slipped 12.55% — and 2025, when it surged 33.85%.
- Year by year, Total Current Liabilities stood at $2.7 billion in 2022, then fell by 12.42% to $2.4 billion in 2023, then retreated by 5.0% to $2.3 billion in 2024, then jumped by 33.85% to $3.0 billion in 2025, then fell by 1.48% to $3.0 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $3.0 billion, $3.0 billion, and $3.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 3.69 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Bn |
| Dec 31, 2025 | 3.05 Bn |
| Sep 30, 2025 | 2.99 Bn |
| Jun 30, 2025 | 2.42 Bn |
| Dec 31, 2024 | 2.28 Bn |
| Sep 30, 2024 | 2.46 Bn |
| Jun 30, 2024 | 2.34 Bn |
| Mar 31, 2024 | 2.27 Bn |
| Dec 31, 2023 | 2.40 Bn |
| Sep 30, 2023 | 2.51 Bn |
| Jun 30, 2023 | 2.41 Bn |
| Mar 31, 2023 | 2.60 Bn |
| Dec 31, 2022 | 2.74 Bn |
| Sep 30, 2022 | 2.33 Bn |
| Jun 30, 2022 | 2.32 Bn |
| Mar 31, 2022 | 2.25 Bn |
| Dec 31, 2021 | 2.47 Bn |
| Sep 30, 2021 | 2.38 Bn |
| Jun 30, 2021 | 2.20 Bn |
| Mar 31, 2021 | 1.97 Bn |